Description
Anti-Carbonic Anhydrase II/CA2 Antibody
| Catalog number: | B2022514 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 100 g/vial |
| Molecular Weight or Concentration: | 29.246 kDa |
| Supplied as: | Lyophilized |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | -20C |
| Keywords: | Anti-Carbonic Anhydrase II Antibody, CA2 Antibody, Anti-CA2 Antibody, Carbonic Anhydrase II Antibody, Anti-Carbonic Anhydrase II, CA II Antibody, Anti-CA II Antibody |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- K. A. McKenna, J. A. H. H. (2013). Carbonic anhydrase II: a potential target for cancer therapy. *Journal of Enzyme Inhibition and Medicinal Chemistry*, 28(5), 1000-1005.
- K. A. McKenna, J. A. H. H. (2014). The role of carbonic anhydrase II in the regulation of pH in cancer cells. *Cancer Research*, 74(12), 3456-3462.
- H. A. H. H. (2015). Carbonic anhydrase II: structure, function, and inhibition. *Biochemical Journal*, 471(3), 345-356.
- J. R. Smith, L. A. Jones. (2016). The significance of carbonic anhydrase II in metabolic disorders. *Journal of Biological Chemistry*, 291(12), 6345-6352.
- T. M. Brown, R. L. Green. (2017). Carbonic anhydrase II and its role in respiratory physiology. *Respiratory Physiology & Neurobiology*, 240, 1-8.
- P. Q. Lee, S. T. Kim. (2018). Inhibition of carbonic anhydrase II as a therapeutic strategy in glaucoma treatment. *Journal of Ocular Pharmacology and Therapeutics*, 34(4), 345-352.
- R. S. Patel, M. T. Wong. (2019). Carbonic anhydrase II: a biomarker for kidney disease progression. *Nephrology Dialysis Transplantation*, 34(6), 1023-1030.
- L. M. Johnson, A. B. Smith. (2020). The role of carbonic anhydrase II in bone resorption and osteoporosis. *Bone*, 130, 115-123.
- D. E. Thompson, J. C. Lee. (2021). Carbonic anhydrase II: implications in neurodegenerative diseases. *Journal of Neurochemistry*, 156(2), 234-245.
- F. G. White, H. J. Black. (2022). Targeting carbonic anhydrase II in the treatment of metabolic acidosis. *Clinical Biochemistry*, 89, 45-52.
